Navigating the 505(b)(2) Pathway: No Two Drugs Are Alike
The Premier Consulting Blog
SEPTEMBER 11, 2024
However, the change in RoA required a single-species, one-month good laboratory practice (GLP) toxicology study. From a clinical pharmacology perspective, the sponsors also needed to establish a scientific bridge for relying on the data contained in the product labeling of the LD. Human factors.
Let's personalize your content